Signaling pathways
-
BA3026 TezacitabineSummary: Tezacitabine is an antimetabolite with cell growth inhibition and cytotoxicity and is a nucleoside analog. - BA3027 CA224Summary: CA224 is a selective, orally active inhibitor.
- BA3028 S65487Summary: S65487 (VOB560) is a potent and selective inhibitor and a precursor of S55746.
- BA3029 XST-14Summary: XST-14 is a potent, competitive and highly selective inhibitor.
- BA3030 JAK2-IN-7Summary: JAK2-IN-7 is a selective inhibitor.
- BA3031 Thalidomide-Piperazine-PEG1-COOHSummary: Thalidomide-Piperazine-PEG1-COOH is a synthetic E3 ligase ligand-linker coupler.
- BA3032 AQX-435Summary: AQX-435 is a potent activator.
- BA3033 L6H21Summary: L6H21, a derivative, is an orally effective inhibitor of specific myeloid differentiation proteins.
- BA3034 DJ001Summary: DJ001 is a highly specific, selective and non-competitive protein tyrosine phosphatase-σ inhibitor.
- BA3035 CRT0066101Summary: CRT0066101 is a potent inhibitor with oral activity.